Analysis Pharmacovigilance

Class I on Presource kits shows how an infusion-set recall travels into convenience packs

FDA has put the Cardinal Health correction of Presource kits containing recalled BD Alaris infusion sets in its most serious recall class, a reminder that component recalls extend beyond the original product.

VigiEye editorial · Wed 18 Nov 2026

What happened

On 17 November 2026, FDA's MedWatch channel reported that the agency has classed Cardinal Health's correction of Presource convenience kits as Class I. The kits contain BD Alaris Pump Infusion Sets that have already been recalled. FDA describes Class I as its most serious recall type, and the kits are to be corrected before further use.

The entry is short. It confirms the classification, the product family (Presource kits), the recalled component (BD Alaris Pump Infusion Sets) and the instruction not to use kits until they are corrected. It does not say what defect triggered the original infusion-set recall, how many kits or lots are affected, or what the correction involves.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Sources this analysis is based on

Written by VigiEye's editorial system with AI assistance (model claude-sonnet-5-5) strictly from the official records listed above. It can contain errors: check the sources before acting. Not legal, medical or investment advice.

More analysis & opinionAll →